Jonathan R Monson's most recent trade in Boston Scientific Corp. was a trade of 1,090 Common Stock done . Disclosure was reported to the exchange on Aug. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Boston Scientific | Jonathan R. Monson | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2025 | 1,090 | 35,817 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Jonathan R. Monson | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2025 | 1,090 | 0 | - | - | Restricted Stock Units | |
| Boston Scientific | Jonathan R. Monson | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.41 per share. | 02 Aug 2025 | 528 | 35,289 (0%) | 0% | 105.4 | 55,656 | Common Stock |
| Boston Scientific | Jonathan R. Monson | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 22,173 | 22,173 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Jonathan R. Monson | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 8,350 | 8,350 | - | - | Restricted Stock Units | |
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 16 Feb 2024 | 1,000 | 38,006 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Monson Jonathan R. | SVP, Global Controller and CAO | 16 Feb 2024 | 1,000 | 1,000 | - | - | Restricted Stock Units | ||
| Boston Scientific | Monson Jonathan R. | SVP, Global Controller and CAO | 16 Feb 2024 | 990 | 1,980 | - | - | Restricted Stock Units | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 16 Feb 2024 | 990 | 37,433 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 16 Feb 2024 | 638 | 0 | - | - | Deferred Stock Units | ||
| Boston Scientific | Monson Jonathan R. | SVP, Global Controller and CAO | 16 Feb 2024 | 638 | 38,240 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Jonathan Monson R. | SVP, Global Controller and CAO | 16 Feb 2024 | 427 | 37,006 (0%) | 0% | 65.8 | 28,105 | Common Stock | |
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 16 Feb 2024 | 404 | 37,602 (0%) | 0% | 65.8 | 26,591 | Common Stock | |
| Boston Scientific | Monson R. Jonathan | SVP, Global Controller and CAO | 16 Feb 2024 | 258 | 37,982 (0%) | 0% | 65.8 | 16,982 | Common Stock | |
| Boston Scientific | R. Jonathan Monson | SVP, Global Controller and CAO | 14 Feb 2024 | 1,057 | 36,931 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | R. Monson Jonathan | SVP, Global Controller and CAO | 14 Feb 2024 | 1,057 | 3,173 | - | - | Restricted Stock Units | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 14 Feb 2024 | 488 | 36,443 (0%) | 0% | 66.0 | 32,184 | Common Stock | |
| Boston Scientific | R. Monson Jonathan | SVP, Global Controller and CAO | 12 Feb 2024 | 14,180 | 14,180 | - | - | Stock Option (Right to Buy) | ||
| Boston Scientific | R. Jonathan Monson | SVP, Global Controller and CAO | 12 Feb 2024 | 4,616 | 4,616 | - | - | Restricted Stock Units | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 01 Dec 2023 | 10,543 | 10,543 | - | - | Stock Option (Right to Buy) | ||
| Boston Scientific | Monson Jonathan R. | SVP, Global Controller and CAO | 01 Dec 2023 | 3,562 | 3,562 | - | - | Restricted Stock Units | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 02 Aug 2023 | 1,090 | 2,180 | - | - | Restricted Stock Units | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 02 Aug 2023 | 1,090 | 36,361 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 02 Aug 2023 | 487 | 35,874 (0%) | 0% | 50.6 | 24,652 | Common Stock | |
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 01 Jul 2023 | 729 | 35,597 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 01 Jul 2023 | 729 | 0 | - | - | Deferred Stock Units | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 01 Jul 2023 | 326 | 35,271 (0%) | 0% | 54.1 | 17,633 | Common Stock | |
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 31 Mar 2023 | 5,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 31 Mar 2023 | 5,000 | 34,868 (0%) | 0% | 50 | 250,000 | Common Stock | |
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 31 Mar 2023 | 5,000 | 39,868 (0%) | 0% | 12.9 | 64,450 | Common Stock | |
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 01 Mar 2023 | 5,000 | 39,868 (0%) | 0% | 12.9 | 64,450 | Common Stock | |
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 01 Mar 2023 | 5,000 | 34,868 (0%) | 0% | 46.7 | 233,315 | Common Stock | |
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 01 Mar 2023 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 21 Feb 2023 | 623 | 35,120 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 21 Feb 2023 | 623 | 0 | - | - | Deferred Stock Units | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 21 Feb 2023 | 252 | 34,868 (0%) | 0% | 46.2 | 11,650 | Common Stock | |
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 16 Feb 2023 | 1,000 | 34,535 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 16 Feb 2023 | 1,000 | 2,000 | - | - | Restricted Stock Units | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 16 Feb 2023 | 990 | 33,991 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 16 Feb 2023 | 990 | 2,970 | - | - | Restricted Stock Units | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 16 Feb 2023 | 637 | 34,751 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 16 Feb 2023 | 637 | 638 | - | - | Deferred Stock Units | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 16 Feb 2023 | 456 | 33,535 (0%) | 0% | 46.5 | 21,195 | Common Stock | |
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 16 Feb 2023 | 421 | 34,114 (0%) | 0% | 46.5 | 19,593 | Common Stock | |
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 16 Feb 2023 | 254 | 34,497 (0%) | 0% | 46.5 | 11,821 | Common Stock | |
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 15 Feb 2023 | 739 | 0 | - | - | Deferred Stock Units | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 15 Feb 2023 | 739 | 33,341 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 15 Feb 2023 | 340 | 33,001 (0%) | 0% | 47.3 | 16,079 | Common Stock | |
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 14 Feb 2023 | 12,702 | 12,702 | - | - | Stock Option (Right to Buy) | ||
| Boston Scientific | Jonathan R. Monson | SVP, Global Controller and CAO | 14 Feb 2023 | 4,230 | 4,230 | - | - | Restricted Stock Units | ||
| Boston Scientific | Jonathan R. Monson | VP, Global Controller and CAO | 14 Jun 2021 | 7,901 | 10,000 | - | - | Stock Option (Right to Buy) | ||
| Boston Scientific | Jonathan R. Monson | VP, Global Controller and CAO | 14 Jun 2021 | 7,901 | 44,963 (0%) | 0% | 12.9 | 101,844 | Common Stock | |
| Boston Scientific | Jonathan R. Monson | VP, Global Controller and CAO | 14 Jun 2021 | 7,901 | 37,062 (0%) | 0% | 42.8 | 338,038 | Common Stock | |
| Boston Scientific | Jonathan R. Monson | VP, Global Controller and CAO | 14 Jun 2021 | 5,000 | 42,062 (0%) | 0% | 13.1 | 65,400 | Common Stock | |
| Boston Scientific | Jonathan R. Monson | VP, Global Controller and CAO | 14 Jun 2021 | 5,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Boston Scientific | Jonathan R. Monson | VP, Global Controller and CAO | 14 Jun 2021 | 5,000 | 37,062 (0%) | 0% | 42.9 | 214,700 | Common Stock |